Walleye Trading
IRWD icon

Walleye Trading’s Ironwood Pharmaceuticals IRWD Stock Holding History

Walleye Trading’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,900
Closed -$147K – 4595
2024
Q1 		$147K Buy
+16,900
New +$205K ﹤0.01% 3589
2020
Q3 		– Sell
-12,200
Closed -$126K – 4363
2020
Q2 		$126K Buy
+12,200
New +$125K ﹤0.01% 3376

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Walleye Trading's IRWD Position: Q3 2021 in Review

Walleye Trading sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2021, closing a stake of 14,943 shares — an estimated $192K sold.

Walleye Trading first reported a position in IRWD in Q4 2015 and held it in 4 quarters. The position peaked at $192K in Q2 2021. 227 funds tracked by Wall St. Rank hold IRWD as of Q3 2021.

  • Walleye Trading reported no remaining Ironwood Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Walleye Trading sold 14,943 Ironwood Pharmaceuticals shares in Q3 2021, an estimated $192K.
  • Walleye Trading first reported a position in Ironwood Pharmaceuticals in Q4 2015 and held it in 4 quarters.
  • Walleye Trading's Ironwood Pharmaceuticals position peaked at $192K in Q2 2021.
  • 227 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2021.

Based on Walleye Trading's 13F filing for Q3 2021, filed 15 Nov 2021.